221 related articles for article (PubMed ID: 33246952)
1. PBRM1 and the glycosylphosphatidylinositol biosynthetic pathway promote tumor killing mediated by MHC-unrestricted cytotoxic lymphocytes.
Menasche BL; Davis EM; Wang S; Ouyang Y; Li S; Yu H; Shen J
Sci Adv; 2020 Nov; 6(48):. PubMed ID: 33246952
[TBL] [Abstract][Full Text] [Related]
2. A major chromatin regulator determines resistance of tumor cells to T cell-mediated killing.
Pan D; Kobayashi A; Jiang P; Ferrari de Andrade L; Tay RE; Luoma AM; Tsoucas D; Qiu X; Lim K; Rao P; Long HW; Yuan GC; Doench J; Brown M; Liu XS; Wucherpfennig KW
Science; 2018 Feb; 359(6377):770-775. PubMed ID: 29301958
[TBL] [Abstract][Full Text] [Related]
3. Influence of glycosylphosphatidylinositol-linked H-2Dd molecules on target cell protection and natural killer cell specificity in transgenic mice.
Sentman CL; Olsson-Alheim MY; Lendahl U; Kärre K
Eur J Immunol; 1996 Sep; 26(9):2127-32. PubMed ID: 8814257
[TBL] [Abstract][Full Text] [Related]
4. Killing of human immunodeficiency virus-infected primary T-cell blasts by autologous natural killer cells is dependent on the ability of the virus to alter the expression of major histocompatibility complex class I molecules.
Bonaparte MI; Barker E
Blood; 2004 Oct; 104(7):2087-94. PubMed ID: 15117765
[TBL] [Abstract][Full Text] [Related]
5. Major histocompatibility complex-unrestricted cytolytic activity of human T cells. Analysis of precursor frequency and effector phenotype.
Patel SS; Thiele DL; Lipsky PE
J Immunol; 1987 Dec; 139(11):3886-95. PubMed ID: 3500232
[TBL] [Abstract][Full Text] [Related]
6. Anti-CD3 and phorbol myristate acetate regulation of MHC unrestricted T cell cytotoxicity. Lack of a requirement for CD3/T cell receptor complex expression during tumor cell lysis.
Thiele DL; Patel SS; Lipsky PE
J Immunol; 1988 May; 140(9):3253-60. PubMed ID: 2966209
[TBL] [Abstract][Full Text] [Related]
7. Dual effects of cytokines in regulation of MHC-unrestricted cell mediated cytotoxicity.
Reiter Z
Crit Rev Immunol; 1993; 13(1):1-34. PubMed ID: 8466640
[TBL] [Abstract][Full Text] [Related]
8. Involvement of CD28 in MHC-unrestricted cytotoxicity mediated by a human natural killer leukemia cell line.
Azuma M; Cayabyab M; Buck D; Phillips JH; Lanier LL
J Immunol; 1992 Aug; 149(4):1115-23. PubMed ID: 1380031
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of MHC-unrestricted cytotoxic activity of human CD56+ CD3- natural killer (NK) cells and CD3+ T cells by rhamnogalacturonan: target cell specificity and activity against NK-insensitive targets.
Zhu HG; Zollner TM; Klein-Franke A; Anderer FA
J Cancer Res Clin Oncol; 1994; 120(7):383-8. PubMed ID: 7514604
[TBL] [Abstract][Full Text] [Related]
10. The transcription factor interferon regulatory factor-1 is essential for natural killer cell function in vivo.
Duncan GS; Mittrücker HW; Kägi D; Matsuyama T; Mak TW
J Exp Med; 1996 Nov; 184(5):2043-8. PubMed ID: 8920893
[TBL] [Abstract][Full Text] [Related]
11. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.
Brando C; Mukhopadhyay S; Kovacs E; Medina R; Patel P; Catina TL; Campbell KS; Santoli D
J Leukoc Biol; 2005 Aug; 78(2):359-71. PubMed ID: 15937142
[TBL] [Abstract][Full Text] [Related]
12. MUC1-C Dictates PBRM1-Mediated Chronic Induction of Interferon Signaling, DNA Damage Resistance, and Immunosuppression in Triple-Negative Breast Cancer.
Yamashita N; Morimoto Y; Fushimi A; Ahmad R; Bhattacharya A; Daimon T; Haratake N; Inoue Y; Ishikawa S; Yamamoto M; Hata T; Akiyoshi S; Hu Q; Liu T; Withers H; Liu S; Shapiro GI; Yoshizumi T; Long MD; Kufe D
Mol Cancer Res; 2023 Mar; 21(3):274-289. PubMed ID: 36445328
[TBL] [Abstract][Full Text] [Related]
13. Natural Killer Cells Suppress T Cell-Associated Tumor Immune Evasion.
Freeman AJ; Vervoort SJ; Ramsbottom KM; Kelly MJ; Michie J; Pijpers L; Johnstone RW; Kearney CJ; Oliaro J
Cell Rep; 2019 Sep; 28(11):2784-2794.e5. PubMed ID: 31509742
[TBL] [Abstract][Full Text] [Related]
14. Role for major histocompatibility complex class I in regulating natural killer cell-mediated killing of virus-infected cells.
Kaufman DS; Schoon RA; Leibson PJ
Proc Natl Acad Sci U S A; 1992 Sep; 89(17):8337-41. PubMed ID: 1325654
[TBL] [Abstract][Full Text] [Related]
15. Reduction of MHC-I expression limits T-lymphocyte-mediated killing of Cancer-initiating cells.
Morrison BJ; Steel JC; Morris JC
BMC Cancer; 2018 Apr; 18(1):469. PubMed ID: 29699516
[TBL] [Abstract][Full Text] [Related]
16. The role of cell surface recognition structures in the initiation of MHC-unrestricted 'promiscuous' killing by T cells.
Thiele DL; Lipsky PE
Immunol Today; 1989 Nov; 10(11):375-81. PubMed ID: 2532884
[TBL] [Abstract][Full Text] [Related]
17. Interferon--a major regulator of natural killer cell-mediated cytotoxicity.
Reiter Z
J Interferon Res; 1993 Aug; 13(4):247-57. PubMed ID: 7693829
[TBL] [Abstract][Full Text] [Related]
18. Cellular mechanisms of lymphocyte-mediated lysis of tumor cells.
Arancia G; Malorni W; Donelli G
Ann Ist Super Sanita; 1990; 26(3-4):369-84. PubMed ID: 2151107
[TBL] [Abstract][Full Text] [Related]
19. Manifestation of the MHC-unrestricted killing potential of a cytotoxic T cell clone requires activation in response to MHC-restricted self-presentation of antigen.
Dick T; Staege MS; Reichmann G; Reske-Kunz AB
J Immunol; 1993 Apr; 150(7):2575-83. PubMed ID: 8454844
[TBL] [Abstract][Full Text] [Related]
20. Antibodies to adhesion molecules inhibit the lytic function of MHC-unrestricted cytotoxic cells by preventing their activation.
Zarcone D; Viale O; Cerruti G; Tenca C; Malorni W; Arancia G; Iosi F; Galandrini R; Velardi A; Moretta A
Cell Immunol; 1992 Sep; 143(2):389-404. PubMed ID: 1380897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
